Company & Sponsor Intelligence
Peking University Third Hospital
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials3
Recruiting3
Completed0
Countries1
Therapeutic footprint
out_of_scopesleep_disorders
Indexed studies
NCT06967363Multimodal Imaging and Biospecimen Collection for Low Back Pain (LBPB)
sleep_disorders · ChinaNOT_YET_RECRUITING
sleep_disorders · ChinaNOT_YET_RECRUITING
NCT07153666A Real-world Study on the Influencing Factors of Efficacy of Ruxolitinib Cream in Vitiligo
out_of_scope · ChinaRECRUITING
out_of_scope · ChinaRECRUITING
NCT07423013Evaluating the Efficacy and Safety of Teprotumumab N01 in Patients With Thyroid Eye Disease.
out_of_scope · ChinaNA
out_of_scope · ChinaNA
Intelligence layer updated: 2026-10-12 03:39:50.393311+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →